You are here: Home > Our expertise > Achievements

« From bench to business », including the market study, business model definition, business and financial plan, strategic and operational marketing, financing and implementation : 

• Q4, 2011 : MasThercell, Gosselies : cell-based ATMPs CMO.
• Q4, 2013 : RevaTis, Liège : veterinary regenerative medicine
• Q2, 2014 : Amhyspin, Liège : the next generation of hybridoma cell lines
• Q4, 2015 : SynAbs, Liège : SynAbs generates rat and mice antibodies

• An innovative process to stimulate the hybridoma cell lines : In Vitro Diagnostic market and business model.
• The PRP use in the human orthopaedic sector.
• Cell therapy, Contract Development & Manufacturing services : the manufacturing and clinical pipeline landscape.
• The cell therapy GMP infrastructures : a European landscape.
• A new recombinant avian cell line : market potential and comparison to the recombinant and transgenic industrial tools.
• The equine and veterinary joint regenerative treatments, a review : PRP, extracellular matrix components, stem cells and their combinations.